Liability Disclaimer

The references to publications hereunder serve only as illustrations for various fields of research and applications as they are reported in publicly available scientific literature. MosaMedix B.V. does not make claims, promises, or guarantees about the accuracy, completeness, or adequacy of this information and MosaMedix B.V. expressly disclaims liability for the content and for views and opinions of authors expressed herein, which do not necessarily constitute or reflect views or opinions of MosaMedix B.V.

Any links to external Web sites and/or non - MosaMedix B.V. information provided on MosaMedix website pages are provided as a courtesy.They should not be construed as an endorsement by MosaMedix B.V. of the content or views of the linked materials.

Samples from Scientific Literature

Vangestel C, Peeters M, Mees G, Oltenfreiter R, Boersma HH, Elsinga PH, Reutelingsperger C, Van Damme N, De Spiegeleer B, Van de Wiele C. In vivo imaging of apoptosis in oncology: An update. Molecular imaging. 2011

De Saint-Hubert M, Mottaghy FM, Vunckx K, Nuyts J, Fonge H, Prinsen K, Stroobants S, Mortelmans L, Deckers N, Hofstra L, Reutelingsperger CP, Verbruggen A, Rattat D. Site-specific labeling of 'second generation' annexin v with 99mtc(co)3 for improved imaging of apoptosis in vivo. Bioorg Med Chem. 2010;18:1356-1363

De Saint-Hubert M, Wang H, Devos E, Vunckx K, Zhou L, Reutelingsperger C, Verbruggen A, Mortelmans L, Ni Y, Mottaghy FM. Preclinical imaging of therapy response using metabolic and apoptosis molecular imaging. Mol Imaging Biol. 2010

Vangestel C, Peeters M, Oltenfreiter R, D'Asseler Y, Staelens S, Van Steenkiste M, Philippe J, Kusters D, Reutelingsperger C, Van Damme N, Van de Wiele C. In vitro and in vivo evaluation of [99mtc]-labeled tricarbonyl his-annexin a5 as an imaging agent for the detection of phosphatidylserine-expressing cells. Nucl Med Biol. 2010;37:965-975

De Saint-Hubert M, Prinsen K, Mortelmans L, Verbruggen A, Mottaghy FM. Molecular imaging of cell death. Methods. 2009;48:178-187 Fonge H, de Saint Hubert M, Vunckx K, Rattat D, Nuyts J, Bormans G, Ni Y, Reutelingsperger C, Verbruggen A. Preliminary in vivo evaluation of a novel 99mtc-labeled hynic-cys-annexin a5 as an apoptosis imaging agent. Bioorg Med Chem Lett. 2008;18:3794-3798

McQuade P, Belanger M-J, Meng X, Guenther I, Krause S, Gonzalez Trotter D, Reutelingsperger C, Hostetler E, Klimas M, Mehmet H, Cook J. Comparison of the in vivo distribution of four different annexin a5 adducts in rhesus monkeys. International Journal of Molecular Imaging. 2011;2011:1-9

Agarwal A, Mackey MA, El-Sayed MA, Bellamkonda RV. Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano. 2011 inpress (

"Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells."
K Schutters1, DHM Kusters1, MLL Chatrou1, T Montero-Melendez2, M Donners3, NM Deckers1, DV Krysko4,5, P Vandenabeele4,5, M Perretti2, LJ Schurgers1 and CPM Reutelingsperger*,1 Cell Death and Differentiation advance online publication, 7 September 2012; doi:10.1038/cdd.2012.107